From Wikipedia, the free encyclopedia

Semi-protected edit request on 2 October 2023

Remdesivir is an antiviral agent with positive effects on the prognosis of Coronavirus Disease (COVID-19). However, there are concerns about the detrimental effects of remdesivir on kidney function which might consequently lead to Acute Kidney Injury (AKI).13 Apr. 2023 https://www.ncbi.nlm.nih.gov › pmc Acute kidney injury in COVID-19 patients receiving remdesivir - NCBI 102.130.28.14 ( talk) 08:38, 2 October 2023 (UTC) reply

 Not done No source linked. Bon courage ( talk) 08:46, 2 October 2023 (UTC) reply
presuming you mean https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099148/ this, their conclusion was "Our study suggested that remdesivir treatment probably has little or no effect on the risk of AKI in COVID-19 patients." Cannolis ( talk) 11:49, 2 October 2023 (UTC) reply

A little late here but,

I was surprised reading this article that there was very little mention of any of the past criticism of this drug. It sounds like it has had a lot of supporters and detractors since 2020, yet there is very little mention of any of the previous criticism (a couple sentences from what I read). The WHO recently walked back their criticism of the drug WHO recommends against the use of remdesivir in COVID-19 patients

And another recent article supports its use, along with the trials that WHO cites " Study Supports Use of Remdesivir for COVID-19 Patients on Low-Flow Oxygen or No Oxygen (hopkinsmedicine.org)"

So my question is: if the general scientific consensus has agreed that Remdesivir does work, does that mean there is little need of much discussion on any previous detractions or concerns about its quick approval? I would be of the opinion that the FDA not convening outside panels for this drug is notable, but I would like to know what this articles frequent editors think. (more sources: forbes and science.org) 134.134.139.84 ( talk) 18:57, 11 October 2023 (UTC) reply

Any good sources giving an overview? So far as I can see the modern view is that remdesevir is a bit rubbish for COVID. [1] Bon courage ( talk) 19:14, 11 October 2023 (UTC) reply

Semi-protected edit request on 28 January 2024

Possible side effects include death. 73.121.109.117 ( talk) 11:52, 28 January 2024 (UTC) reply

 Not done No source. Bon courage ( talk) 12:06, 28 January 2024 (UTC) reply
From Wikipedia, the free encyclopedia

Semi-protected edit request on 2 October 2023

Remdesivir is an antiviral agent with positive effects on the prognosis of Coronavirus Disease (COVID-19). However, there are concerns about the detrimental effects of remdesivir on kidney function which might consequently lead to Acute Kidney Injury (AKI).13 Apr. 2023 https://www.ncbi.nlm.nih.gov › pmc Acute kidney injury in COVID-19 patients receiving remdesivir - NCBI 102.130.28.14 ( talk) 08:38, 2 October 2023 (UTC) reply

 Not done No source linked. Bon courage ( talk) 08:46, 2 October 2023 (UTC) reply
presuming you mean https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099148/ this, their conclusion was "Our study suggested that remdesivir treatment probably has little or no effect on the risk of AKI in COVID-19 patients." Cannolis ( talk) 11:49, 2 October 2023 (UTC) reply

A little late here but,

I was surprised reading this article that there was very little mention of any of the past criticism of this drug. It sounds like it has had a lot of supporters and detractors since 2020, yet there is very little mention of any of the previous criticism (a couple sentences from what I read). The WHO recently walked back their criticism of the drug WHO recommends against the use of remdesivir in COVID-19 patients

And another recent article supports its use, along with the trials that WHO cites " Study Supports Use of Remdesivir for COVID-19 Patients on Low-Flow Oxygen or No Oxygen (hopkinsmedicine.org)"

So my question is: if the general scientific consensus has agreed that Remdesivir does work, does that mean there is little need of much discussion on any previous detractions or concerns about its quick approval? I would be of the opinion that the FDA not convening outside panels for this drug is notable, but I would like to know what this articles frequent editors think. (more sources: forbes and science.org) 134.134.139.84 ( talk) 18:57, 11 October 2023 (UTC) reply

Any good sources giving an overview? So far as I can see the modern view is that remdesevir is a bit rubbish for COVID. [1] Bon courage ( talk) 19:14, 11 October 2023 (UTC) reply

Semi-protected edit request on 28 January 2024

Possible side effects include death. 73.121.109.117 ( talk) 11:52, 28 January 2024 (UTC) reply

 Not done No source. Bon courage ( talk) 12:06, 28 January 2024 (UTC) reply

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook